The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Azadeh Hekmat, Ali Akbar Saboury. 2026; 19. https://doi.org/10.1016/B978-0-443-44173-8.00013-9 |
|
2 |
2026 |
Andrej Rusin, Alan Cocchetto, Carmel Mothersill. Low-Dose Ionizing Radiation and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Review of Recent Evidence and Future Research Directions Toward the Elucidation of a Metabolic, Immunologic, and Signaling Cascade, International Journal of Molecular Sciences. 2026; 27: 6535. https://doi.org/10.3390/ijms27146535 |
|
3 |
2026 |
Ondippili Rudhra, Sanjeev Kumar Singh. Systems-level multi-omics dissection of syndromic and idiopathic autism reveals distinct regulatory architectures, candidate molecular signatures, and potential therapeutic targets, Computers in Biology and Medicine. 2026; 213: 111822111822. https://doi.org/10.1016/j.compbiomed.2026.111822 |
|
4 |
2026 |
Chandrayee Banerjee, Rohit Kumar Singh, Divya Choudhary, MD Nasiruddin Khan, Pankaj Kumar Maurya, Zuber Khan, Sidharth Mehan, Rajaram Samant, Manoj Tongra. Decoding the PI3K/Akt/mTOR–JAK/STAT signaling axis in multiple sclerosis: mechanistic crosstalk and therapeutic opportunities, Immunologic Research. 2026; 74: 72. https://doi.org/10.1007/s12026-026-09808-9 |